This is WashU Innovation
The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.
Explore our innovation community
Needlemans commit $15 million to boost drug discovery
A generous gift from longtime benefactors of Washington University School of Medicine in St. Louis establishes the Needleman Program for Innovation and Commercialization. For a select number of projects, the new program will provide funding to help move promising therapeutics towards the stage where the Food and Drug Administration grants investigational new drug (IND) status.
A device aimed at enabling neurosurgeons and other physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration (FDA) “Breakthrough Device” designation. The device includes technology from Washington University in St. Louis and developed by Cordance Medical Inc., a medical device company in Mountain View, Calif.
Shripad Bhagwat, PhD, a drug development expert with decades of experience in the pharmaceutical and biotech industries, has been named the inaugural senior director of the Needleman Program for Innovation and Commercialization (NPIC) at Washington University in St. Louis.
Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases
Resources for Students & Alumni
The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.